Transplantation tolerance in adult rats using total lymphoid irradiation: permanent survival of skin, heart, and marrow allografts by unknown
TRANSPLANTATION  TOLERANCE  IN ADULT  RATS  USING 
TOTAL  LYMPHOID  IRRADIATION:  PERMANENT 
SURVIVAL  OF  SKIN,  HEART,  AND  MARROW  ALLOGRAFTS* 
BY S. SLAVIN,~ B. REITZ, C. P. BIEBER, H. S. KAPLAN,  AND S. STROBER§ 
(From the Division of lmmunology, Department of Medicine, the Department of Cardiovascular 
Surgery, and the Division of  Radiotherapy, Department of  Radiology, Stanford University School 
of Medicine, Stanford, California 94305) 
Establishment of permanent tolerance to transplantation antigens remains 
the major obstacle in clinical organ transplantation. The rejection phenomenon 
persists despite extensive use of a large variety of immunosuppressive  protocols 
that include radiation,  cytotexic agents, corticosteroids, and anti-lymphocyte 
antisera.  Some interesting experimental approaches to organ transplantation 
are currently under investigation (1-4).  However, none of these is clinically 
applicable at present. 
Recently,  a  new  approach was  developed for  transplanting bone  marrow 
(BM)  I allografts  across  major histocompatability  barriers  with induction  of 
permanent and specific  tolerance  to donor BM-type alloantigens  in mice (5-7). 
Permanent (>300 days)  chimerism was established  in adult  BALB/c (H-2  d/d) 
mice after  treatment  with total  lymphoid irradiation  (TLI),  and infusion  of  107 
C57BL/Ka (H-2  blb)  BM  cells  (7).  TLI consisted  of 17 consecutive  fractions  of 
200 rads (total  cumulative dose of  3,400  rads)  directed  to the major lymphoid 
organs, including  the thymus, spleen, and cervical,  axillary,  mediastinal, 
inguinal,  and mesenteric lymph nodes.  A lead  shield  covered the skull,  lungs, 
ribs,  thoracic  spine,  hind  legs,  and tail  (5,  7).  A similar  radiotherapy  technique 
is routinely  used in humans for the treatment of Hodgkin's disease (8).  The 
specificity  of  the acquired  tolerance  to  the  H-2  b  haplotype in  the  H-2  d  recipients 
was  demonstrated  by  the  normal rejection  pattern  of  a third-party  skin  allograft 
of H-2  k haplotype (C3H/He) with permanent survival of an adjacent  H-2  b 
(C57BL/Ka) graft  (7).  A series  of  in  vitro  experiments  revealed  that  lymphocytes 
from BM  chimeras lost their ability  to respond against either donor- or 
recipient-type  lymphocytes in a one-way mixed lymphocyte  reaction  (MLR) (7). 
Interestingly,  BM-recipient BALB/c mice did  not develop  clinical  signs  of  graft- 
versus-host disease (GVHD)  (7).  The present work confirms and extends 
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previous observations in mice. Adult rats treated with TLI and given infusions 
of aUogeneic BM permanently accepted heterotopically transplanted skin and 
perfused  heart  allografts.  BM  chimeras  were  specifically  tolerant  to  donor 
tissues, and showed no clinical signs of GVHD. 
Materials and Methods 
Animals and Irradiation.  Adult male Lewis (AgB'/'), Brown Norway (BN) (AgB  3/3) and ACI 
(AgB  4~4) rats  purchased  from  Microbiological Associates,  WalkereviUe,  Md.,  were  used  in  all 
experiments.  Rats weighed 250-350  g.  Animals were irradiated  with a  Philips x-ray unit  (250 
kV,  15 mA; Philil~ Electronic Instruments,  Inc.,  Mahwah,  N.J.) at a  rate of 40 rads/min with 
0.25-ram  Cu  and  1.0-ram  A1  filters.  The  source  axis  distance  was  60  cm.  Lewis  allograft 
recipients were treated with 200 rads/day, five times a week to achieve a total dose of 3,400 rads 
before  transplantation.  Animals  were  anesthetized  with  pontebarbital  and  positioned  in  an 
apparatus  with lead shields  (Fig.  D for each radiation treatment.  Two radiation protocols were 
used; one (Fig. 1 A) shielded the skull, lungs, limbs, pelvis, and tail; the other (Fig. 1 B) shielded 
the skull, lungs, and tail, but left the entire pelvis and the forelimbs exposed to x-rays. In both 
cases,  all the major lymphoid organs,  including the thymus and spleen,  were in the radiation 
fields.  Dosimetry  was  verified  using  a  calibrating  ionization  chamber,  and  lithium  fluoride 
thermoluminescence dosimeters. 
Skin,  BM,  and Heart  Transplantation.  Full-thickness  skin  grafts  were  prepared  using  a 
modification of the technique of Billingham and Medawar (9), and they were transplanted to the 
ventral thoracic wall. Grafts were examined daily, and rejection was considered complete when 
they had sloughed off, or an eschar had developed. BM cells obtained from the long bones were 
made into a single cell suspension, and injected into the lateral tail vein of irradiated recipients 
as described previously (7). Heart allografts were anastomosed to the host's abdominal aorta and 
inferior vena cava according to the method of Ono and Lindsey (10). Cardiac allograi% survival 
was monitored by palpation and electrocardiography. Grafts were considered rejected when both 
palpable contractions and electrocardiographic activity were no longer detected.  Skin,  BM, and 
heart allografts were transplanted  to Lewis recipients within 1 day after the completion of TLI. 
Assay for Chimerism.  Survival of BM allografts was measured by the persistence of donor- 
type  lymphocytes  in  the  peripheral  blood.  Donor lymphocytes  were  detected  by  an  in  vitro 
complement-dependent  microcytotoxicity assay  (7)  using  anti-AgB  antisera.  Peripheral  blood 
lymphocytes  purified  on  a  Ficoll-Hypaque  gradient  (11) were  incubated  for  15  rain  at  room 
temperature  with diluted antiserum  in medium 199  (Microbiological Associates) with 5% heat- 
inactivated fetal calf serum.  Rabbit complement, thoroughly absorbed with rat spleen cells (1:1 
for 30  rain  on ice) was  added  (final dilution  1:5), and  the reaction mixture  was  incubated  for 
another 45  rain at room temperature.  Thereafter,  cells were harvested by centrifugation,  and 
resuspended in culture medium. The percentage of cytotoxicity was determined after the addition 
of trypan blue. The net cytotoxicity index was calculated by comparing the number of viable cells 
present after treatment with antiserum to the number present after treatment with normal rat 
serum.  The percentage of donor-type lymphocytes in Lewis recipients was always cross-checked 
by determining the percentage of host-type lymphocytes. In all cases the sum approximated 100 
±  10%. 
Preparation of Antisera.  Specific Lewis anti-ACI, Lewis anti-BN,  BN anti-Lewis,  and ACI 
anti-Lewis  antisera  were  raised  by  immunizing normal  recipients  with  a  skin  allograft,  and 
injecting 50  ×  108 allogeneic spleen cells intraperitoneally 2 wk after graft rejection. Recipients 
were bled 1 wk later.  The antisera  were found to kill 100% of the allogeneic lymphocytes, and 
<5% of syngeneic lymphocytes in the microcytotoxicity test at a dilution of 1:40. 
MLR.  To document  specific transplantation  tolerance,  peripheral  blood lymphocytes  from 
Lewis recipients  were  stimulated  with  allogeneic lymphocytes  from the  BM  donor and  third° 
party strains in the one-way MLR. Cultures contained 0.1  ×  108 responding cells and 0.2  ×  108 
irradiated  (3,000  rads,  in vitro) stimulater cells in 0.2-ml round-bottomed  microculture plates 
using  10%  heat  inactivated  human  AB serum.  Cells were incubated  at  37°C  in  a  5%  CO2-air 
mixture for 72 h,  and then pulsed for 16-18  h  with 1 mCi of [SH]thymidine  (6.7  Ci/mmol; New 
England Nuclear, Boston, Mass.).  Details of the assay were described previously (7). 702  TRANSPLANTATION  TOLERANCE  IN  ADULT  RATS 
FIG.  1.  Double  exposure  roentgenogram  of  anesthetized  rats  in  apparatus  used  for 
irradiation of major lymphoid tissues.  Opaque areas overlying animals are lead shields. 
All tissues protruding from rectangular enclosure were also shielded (shields not shown). 
Radiation ports were confined to lucent areas within rectangular enclosures.  (A),  Most of 
pelvis and forelimbs are covered by shields; (B), whole of pelvis and forelimbs are exposed 
to irradiation. 
Results and Discussion 
Lewis rats  were given TLI with pelvic  and forelimb  shields.  Skin allografts 
were transplanted  1 day  after irradiation  was complete. Lewis recipients 
showed markedly delayed  rejection  of BN  and ACI skin allografts  (mean 
survival  was 39 and 41 days  respectively)  as  compared to  unirradiated  controls 
(of  mean survival  10 days;  Table I). Rejection  of  BN and ACI heart allografts 
was even further delayed  (survival  range, 34->300  days) as compared to 
controls  (survival  range, 9-10 days;  Table If). 
None of  the Lewis  rats  given TLI with  pelvic  and forelimb  shields  developed S.  SLAVIN,  B.  REITZ,  C.  BIEBER,  H.  KAPLAN,  AND  8.  8TROBER 
TABLE  I 
Survival of ACI and BN Skin Allografts on Lewis Rats 
703 
Skin allo-  Number of  Skin allograR mean sur- 
Treatment of  Lewis recipients  graft  donor  rats  vival 
days  (range) 
TLI*  BN  6  39 (33-46) 
TLI*  ACI  6  41  (35-47) 
TLI* +  10  ~ BM cells (BN)  BN  5  43  (36-65) 
TLI* +  1-2 ×  l0  s BM cells (BN)  BN  2  44 (39-49) 
TLI* +  1-3  ×  10  a BM cells (ACI)  ACI  5  32  (21-44) 
TLI  (without pelvic and forelimb  ACI  5  >150  (40->150) 
shields) +  l0  s BM cells (ACI) 
None  BN  4  10 (9-11) 
None  ACI  4  10 (10) 
* TLI with pelvic and forelimb shields. 
TABLE  I~ 
Survival of ACI and BN Heart AUografts in Lewis Rats 
Treatment of  Lewis  Heart allograft  Number of 
Heart allografl survival 
recipients  donor  rats 
days 
TLI*  BN  3  35, 66, 70 
TLI*  ACI  3  77, 80,  >300 
TLI* +  108 BM cells (ACI)  ACI  5  145,  >300,  >300,  >300,  >300 
None  ACI  3  9, 9, 9 
None  BN  5  9,  9, 9, 9,  10 
* TLI with pelvic  and forelimb shields. 
TABLE  HI 
Survival of ACI and BN Bone Marrow Allografts in Lewis Rats 
Treatment of Lewis recipients 
Fraction of definite 
chimeras >100 days 
after transplanta- 
tion* 
Mean of donor-type 
lymphocytes in pe- 
ripheral blood 
TLI§  +  10' BM cells (BN) 
TLI§  +  2  x  108 BM cells (BN) 
TLI§  +  3  x  108 BM cells (BN) 
TLI§  +  108 BM cells (ACI) 
TLI§  +  2  x  108 BM cells (ACI) 
TLI§  +  3  x  108 BM cells (ACI) 
TLI (without pelvic and forelimb shields) 
+  108 BM cells (ACI) 
TLI (without pelvic and forelimb shields) 
+  3  x  108 BM cells (ACI) 
% 
0/7  0 
0/2  0 
0/2  3 
0/5  7 
0/1  6 
0/2  0 
2/4  485 
4/4  575 
* >10% donor-type peripheral blood lymphocytes was considered evidence of definite chimerism. 
Mean of individual values of definite chimeras in each group. 
§ TLI with pelvic and forelimb shields. 
definite stable chirnerisrn  (e.g.  >10% donor type cells) of the peripheral  blood 
lyrnphocytes after the intravenous injection of up to 3 ×  l0  s ACI or BN marrow 
cells  (Table  HI).  However,  Lewis  recipients  given  TLI  without  pelvic  and 
forelimb shields accepted ACI bone marrow  allograi~s,  and exhibited definite 704  TRANSPLANTATION  TOLERANCE  IN  ADULT  RATS 
TABLE IV 
MLR of Peripheral Blood Lymphocytes of Lewis Rats 
Treatment of  Lewis do- 
nors of  responding  cells 
Treatment of  donors  of 
stimulating cells 
Strain  of  do- 
nors of  stimu-  [3H]Thymi" 
dine uptake*  fating  cells 
cpm +_ SD 
None  None  Lewis  382 ± 165 
None  None  ACI  9,247 ± 329 
None  None  BN  12,267 ± 1,462 
None  TLI* +  108 BM cells (ACI)  Lewis  727 --- 367 
(bearing long-term heart 
graft) 
None  TLI§ +  108 BM cells (ACI)  Lewis  9,867 _+ 2,053 
(bearing  long-term  skin 
graft) 
TLI~ +  10  s BM cells (ACI)  None  Lewis  471 ± 152 
(bearing long-term heart 
graft) 
TLI~ + 108 BM cells  (ACI)  None  ACI  804 -+ 159 
(bearing long-term heart 
graft) 
TLI~ + 10  s  BM  cells  (ACI)  None  BN  2,202  +- 159 
(bearing long-term heart 
graft) 
TLI§ + 10  s  BM  cells  (ACI)  None  Lewis  269 +- 140 
(bearing long-term  skin 
graft) 
TLI§ + 10  s  BM  cells  (ACI)  None  ACI  197 -+ 6 
(bearing long-term  skin 
allograft) 
TLI§ +  10  s  BM cells  (ACI)  None  BN  1,203  ± 209 
(bearing long-term  skin 
graft) 
* Mean  ~ SD of triplicate values. One of two experiments is shown. 
* TLI with pelvic and forelimb shields. 
§ TLI without pelvic and forelimb shields. 
chimerism  of the  peripheral  blood lymphocytes in  assays performed 3-10  mo 
after marrow transplantation  (Tables IH, IV). Successful engraftment was also 
a  function of the number of infused BM cells (Table HI). Although the marrow 
donors  and  recipients  differed at the  major histocompatability genetic  region 
(AgB), no clinical evidence of GVHD (e.g. diarrhea,  hunched back, loss of fur) 
was observed in the chimeras. A  similar lack of GVHD was found previously in 
chimeric BALB/c mice given TLI and C57BL/Ka BM cells (7. 
All of the  Lewis recipients  given TLI with pelvic and forelimb shields,  and 
ACI or BN marrow cells, rejected allogeneic skin grafts within  65 days (Table 
I). However, 4 out of 5 Lewis recipients given TLI without pelvic and forelimb 
shields,  and l0 s ACI marrow cells accepted ACI skin grafts for more than  150 
days  (Table  I).  The  latter  four  animals  were  found  to  be  stable  chimeras. 
Definite chimerism was not observed in the one rat that rejected the skin graft 
after 40 days. Two of the Lewis rats bearing ACI skin grafts for more than 150 
days,  were  given  BN  skin  allografts.  These  third-party  skin  grafts  were S.  8LAVIN,  B.  REITZ,  C.  BIEBER,  H.  KAPLAN,  AND  8.  8TROBER  705 
!i!Hi~iiiiiiiiiEH~HiiiiiuiiuEi~uEiiiui~iiR~M~iu~in~Wiii~i~i~M~m~lii~m~ 
H~Hii~uE~i~iiHHi~H~i~iU!Ei~uE~iR~iiiI~iiW~uiEiiE~I~iI~I~ilEEIll 
rIl|l|lllIIlI°l"l  •  II11  l=l"Irllllli  I .....  Iil  IIII  llillllll-llIII  =-"  l'llllilIl=l  II'l  *  lll'lI||-I  =  lllllI-IIIll"  I  I'Irll  = I'r'l'Illl  • ll  •  •  I  III...  hll..I  •  "Ill.  i  ............  h.'i  II !  ....  •  .il.lli...Iii..i  i! ..... li.lI..il  •  ii'i  II.II.  I  •  •  I  .U  .  i  .....  I.. I  n  ....  I  I ...........  I  il  ..  II  .............  I ...........  i..  I.  ,.,h.,l.,l...,h,.i.h.Jh,..  .... !.,lUi..,..i.i..,L,i,.,.,  ........  ,h,l,..l..,h..!.IC,.,  ......  , .......  ,.,,, ...... ,!ihlu..!.,h.,.,,,,!i 
~M~M~!~M~M~!M!~u~!~Mu~~~lull~~1~ 
~u~M~~M~lull~u~M~u~'1~H~lull~M~ 
~~!~!1111~!u~!~~u~u~H~.r'~!~!~!~111 
Ill iti!ll ~  'Ill ~tZ~ll "7'i! rZ'l! i'1!! rZ'l I l'~'l|  "'~!i ~"i!l "Iii  ~"ll  ?II! I]'11  If?ill rZ'U r~'l!! ';'11','~11 "7'II ,~'.'ll ,i'll*Cii  ',i'll" .'~I '..'~I ].-e 
ltl ii!iiiliti  iihl  Iiii~ ii!i~, Iiii~iiih  ili~,llh,  ilia', llii.  iili~' t!ii~ iiti~, Ili~7 iihl  ilii~ llli~ illil~ iiiiI  I!ii~ hlh  !!!t-': h!iliiit-'i  tilil !i!!1 
~M~~ii~~~~u~i7111~!~u~M~ 
~u~uu~u~!~u~!lull~lull~u~~!~!MM~u~ 
~IIu~IIIII~IuI~u~I~i~I~u~nnnniu~u~uI~I~u~'Ill~u~un~n~II~III~I~  IluiIl!lulllliuu!llllluii!ili~lIlili 
i. I I i i In I lnl. IIII I IIII. I II  I lh n i I In i llll l llh n iii i IIIi IIII I u i. I I I n l Inu II  Ih UUh I In n. i i i. i l..i..-" I.. I.  • i.~llll ."  .ll. _H  ii i ||||. n lll hn. i.I II 
fltiftt-~if~ 
fNHNtflt!t  ~N 
N 
~ifHtfltttltfttff~!tttt!tfl 
tTf~ttit~ttttttttlflltl!tt}ttttttll!ltl 
t~tHttflftlttttHttlltlIIIfttlI]ttI!!IItlIitI! 
t~Htltflttttttttt!Itli!tlItt!II!!tI!!itltltli 
f~ffdtfttttttlfiflttltll!tll!lllt~tfitlttll 
TI~If~tftt]Fttttllq r~ttft~!l~ 
I'  ill  '  I  ~ttttlttttltttliihltl  tl,!f!lhilt~t!ihl 
~tt~t~ktttt~tlt~tHtliitl!itlttillf!ffitt 
Ill  Ill  fill  Ill  ~  II~I1~  H~HI~II~I~I~i  ~ ~ 
lillIl  IIlllll  iiiHiiii  filill!IIIiIIIi~l~I~I!#i~  ii~, 
.....................  IIIiHiIIIHIIIHII!rN11~III!  i!!i  ~+I 
................  ...........  HIH  IIIill~HIIIiIlli!II~lilli  ...... 
iiiiiiiii  iii iiiiiiiiii!iIii!ili!liIHLllII  ll!I!fl  I!!  ..... 
~iI.WitJJtL ,~fJli~tJ:  !~ilititi~tl,Ll.ltW!t.t~t!;tt,,I,~+,;  J 
'!':I! t!liitf  lf,itttiiitttttt~ittt~Ht!ti!~tliti  ;;ti !!1 
~  iilhiTtlt!l  !~ttlt,h ttt~tt  ,it. ~t~ttHHtt  i,  ih: 
Fxo. 2.  (A) Electrocardiogram  with V-lead recording from area of abdomen overlying 
heterotopic heart allograR transplanted 360 days earlier.  (B) Electrical  activity  of  both 
host and donor (arrow) hearts are shown. 
rejected within 25 days. This shows that chimeric Lewis rats were specifically 
tolerant to the ACI tissue transplantation antigens. 
We  were unable to demonstrate  definite stable chimerism  in Lewis rats 
given TLI, with pelvic and forelimb shields,  and ACI marrow cells.  However, 4 
out of 5 nonchimeric rats accepted ACI heart allografts permanently  (>300 
days; Table II).  The electrical  activity  of  one of  these long-term heart allografts 
is shown in Fig.  2. ACI skin allografts  transplanted to Lewis rats bearing ACI 
heart allografts  for 300 days were rejected within 20 days. Nevertheless,  the 
heart allografts  persisted for at least  60 days after  the rejection of the skin 
grafts. Preferential acceptance of  heart as compared to skin allografts  in rats 
has been described  previously  in several model  systems  (1, 12). Prolonged 
heart allograft survival in the present experiments  could be explained by 
several mechanisms  including the development  of specific suppressor cells, 
•  enhancing antibodies, and/or low levels  of  chimerism undetected by our assays. 
Peripheral blood lymphocytes from chimeric Lewis rats bearing ACI skin 
grafts showed no reactivity  to ACI or Lewis stimulator cells  in the MLR  assay 
(Table IV). Although the response to BN  cells  was considerably greater than 
that to the Lewis or ACI cells,  it was markedly reduced in comparison to the 
response of  normal Lewis rats (Table IV).  This shows that nonspecific,  as well 
as specific depression  of the in vitro immune  response persists for at least 
several months in the chimeras. A similar pattern of  MLR  reactivity  was also 
observed in Lewis rats bearing long-term ACI heart allografts  (Table IV).  The 
lack of chimerism  in the latter recipients was further documented  by the 706  TRANSPLANTATION  TOLERANCE  IN  ADULT  RATS 
inability of their peripheral blood lymphocytes to stimulate responder cells 
from normal Lewis rats.  On the other  hand, peripheral  blood lymphocytes from 
Lewis recipients  bearing long-term ACI skin allografts  vigorously stimulated 
normal Lewis responder cells. 
The present work extends earlier  observations concerning the induction of 
tissue  transplantation tolerance  in a single  strain  combination (C57BL/Ka --* 
BALB/c) of mice using TLI. The results  reported herein show that successful 
transplantation of allogeneic  BM  without GVHD  can be achieved in rats as 
well as in mice, and that TLI can be used to obtain  permanent survival of 
perfused  organ allografts.  Development of  stable  BM chimerism in  rats  required 
the use of  radiation  ports similar  to those  used in mice (e.g.,  inclusion  of  the 
pelvis and forelimbs), and transfer of adequate numbers of BM  cells.  This 
suggests that extensive marrow as well  as lymphoid irradiation  is required for 
successful  allogeneic  marrow engraRment. Radiotherapy techniques similar  to 
those described above are routinely used to treat lymphoid malignancies  in 
humans, and have been shown to  be relatively  safe  (8).  These techniques have 
considerable  potential  application  to  clinical  BM and perfused  organ transplan- 
tation. 
Summary 
Lewis  rats  given  total  lymphoid irradiation  (TLI)  accepted  bone  marrow 
allograi~  from  AgB-incompatible donors.  The  chimeras  showed  no  clinical 
signs of graft-versus-host disease. Skin allografts from the marrow donor strain 
survived for more than 150 days on the chimeras. However, third-party skin 
grafts were rejected promptly. Although heart allograi~s survived more than 300 
days in  Lewis recipients  given TLI and bone  marrow  allografis,  detectable 
levels of chimerism were not required for permanent survival. 
We thank G. Garrelts  and C. M. Johnson for  their  valuable technical  assistance. 
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